EUVIMEDEUVIMED entdecken
Open Access

Tyrosine kinase inhibitors in first-line treatment of advanced NSCLC with epidermal growth factor receptor mutations: Real-world data from Vietnam

Khanh Toan Nguyen, Thi Huong Pham, VAN Lam Ngo, VAN Tuan Bui, VAN Nhat Nguyen, Thi Phuong Thao Nguyen, Thi Khanh Ha Nguyen, Thi Thuy VAN Nguyen

Oncology Research · 2025

DOI: 10.32604/or.2025.061905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Khanh Toan Nguyen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology 2, Nghe An Oncology Hospital, Vinh City, 43000, Vietnam. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Protein Kinase Inhibitors, Lung Neoplasms, Mutation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungProtein Kinase InhibitorsLung NeoplasmsMutationHumansMaleErbB ReceptorsFemaleMiddle AgedAgedRetrospective StudiesVietnamAdultAged, 80 and overErlotinib HydrochlorideAfatinibGefitinibProgression-Free SurvivalTreatment OutcomeAcrylamidesTyrosine Kinase InhibitorsAniline CompoundsIndolesPyrimidines

Stichwörter der Autor:innen

AfatinibEGFRErlotinibGefitinibNon-small-cell lung cancerOsimertinib

Substanzen

Protein Kinase InhibitorsErbB ReceptorsEGFR protein, humanErlotinib HydrochlorideAfatinibGefitinibosimertinibAcrylamidesTyrosine Kinase InhibitorsAniline Compounds

Autor:innen und Institutionen

  • Department of Medical Oncology 2, Nghe An Oncology Hospital, Vinh City, 43000, Vietnam.

Zitieren

APA

Nguyen, K. T., Pham, T. H., Ngo, V. L., Bui, V. T., Nguyen, V. N., Nguyen, T. P. T., Nguyen, T. K. H., & Nguyen, T. T. V. (2025). Tyrosine kinase inhibitors in first-line treatment of advanced NSCLC with epidermal growth factor receptor mutations: Real-world data from Vietnam. Oncology Research. https://doi.org/10.32604/or.2025.061905

Vancouver

Nguyen KT, Pham TH, Ngo VL, Bui VT, Nguyen VN, Nguyen TPT, et al. Tyrosine kinase inhibitors in first-line treatment of advanced NSCLC with epidermal growth factor receptor mutations: Real-world data from Vietnam. Oncology Research. 2025. doi:10.32604/or.2025.061905

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Khanh Toan and Pham, Thi Huong and Ngo, VAN Lam and Bui, VAN Tuan and Nguyen, VAN Nhat and Nguyen, Thi Phuong Thao and Nguyen, Thi Khanh Ha and Nguyen, Thi Thuy VAN},
  title = {Tyrosine kinase inhibitors in first-line treatment of advanced NSCLC with epidermal growth factor receptor mutations: Real-world data from Vietnam},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.061905}
}
Kostenlos starten →